Clinical trial · Expanded Access
Expanded Access Use of INCB054329 to Treat a Single Patient With Metastatic Renal Cell Carcinoma
NCT03896815CI-TRIAL-00037873no longer availableClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Expanded access use of INCB054329 to treat a single patient with metastatic renal cell carcinoma.
Conditions
Conditions (0)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
Data not yet available
No condition recorded.
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| INCB054329 | Drug | — | UNRESOLVED |
Eligibility
Eligibility (as posted)
Show eligibility criteria text
Inclusion Criteria: \- Exclusion Criteria: \-
References
Publications (0)
Data not yet available
No reference posted for this study.